Data from the American Cancer Society show that in 2012, North America had the highest incidence of childhood cancer of any other area.
Throughout the projected period, the nucleic acid testing market is anticipated to develop at the quickest rate in Asia Pacific. This is a result of the rising demand for rapid and effective diagnostic tests as well as the increased efforts of the key market players to broaden their geographic reach in this area. For instance, Qiagen N.V. introduced their careHPV test in China in March 2013. CareHPV is a molecular diagnostic test created for low-resource settings, such as those without electricity, water, or laboratories, to screen for high risk human papillomavirus (HPV). In 2012, Qiagen also received certification for careHPV from China's State Food and Drug Administration (SFDA).
Read More:
https://knackersblogger.blogspot.com/2023/03/nucleic-acid-testing-market-global.html
Comments
0 comment